- Home
- AKTX vs IRIX Comparison
AKTX vs IRIX Comparison
Compare AKTX & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- IRIX
- Stock Information
- Founded
- AKTX N/A
- IRIX 1989
- Country
- AKTX United States
- IRIX United States
- Employees
- AKTX N/A
- IRIX N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AKTX Health Care
- IRIX Health Care
- Exchange
- AKTX Nasdaq
- IRIX Nasdaq
- Market Cap
- AKTX 34.7M
- IRIX 27.5M
- IPO Year
- AKTX N/A
- IRIX 1996
- Fundamental
- Price
- AKTX $1.16
- IRIX $1.64
- Analyst Decision
- AKTX
- IRIX Hold
- Analyst Count
- AKTX 0
- IRIX 1
- Target Price
- AKTX N/A
- IRIX $2.00
- AVG Volume (30 Days)
- AKTX 26.4K
- IRIX 31.2K
- Earning Date
- AKTX 02-15-2025
- IRIX 03-25-2025
- Dividend Yield
- AKTX N/A
- IRIX N/A
- EPS Growth
- AKTX N/A
- IRIX N/A
- EPS
- AKTX N/A
- IRIX N/A
- Revenue
- AKTX N/A
- IRIX $48,431,000.00
- Revenue This Year
- AKTX N/A
- IRIX N/A
- Revenue Next Year
- AKTX N/A
- IRIX $5.44
- P/E Ratio
- AKTX N/A
- IRIX N/A
- Revenue Growth
- AKTX N/A
- IRIX N/A
- 52 Week Low
- AKTX $0.90
- IRIX $1.27
- 52 Week High
- AKTX $4.40
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- AKTX 45.74
- IRIX 47.20
- Support Level
- AKTX $1.07
- IRIX $1.61
- Resistance Level
- AKTX $1.39
- IRIX $1.68
- Average True Range (ATR)
- AKTX 0.12
- IRIX 0.05
- MACD
- AKTX -0.01
- IRIX -0.00
- Stochastic Oscillator
- AKTX 27.69
- IRIX 33.33
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.